Experts discuss safety data of anti-vascular endothelial growth factor (Anti-VEGF) agents while highlighting the importance of sharing this information with patients and relevant care providers.
https://www.afinalwarning.com/515217.html (Natural News) A British study using real-world data has shown that 25 percent of vaccinated people experience mild side effects after COVID-19 immunization. Researchers looked at data they obtained through an app that tracks the COVID-19 pandemic in the U.K. for their paper. They found that the mild side effects – the most common being headache – usually lasted two days before disappearing on their own.
King’s College London scientists led by epidemiology professor Tim Spector analyzed data from the ZOE COVID Symptom Study App. They looked at information provided by more than 620,000 users who reported side effects. The users received either the Pfizer/BioNTech or AstraZeneca COVID-19 vaccine within the period of Dec. 8 and March 10. Both vaccines are approved for use in the U.K., alongside the Moderna mRNA vaccine candidate.
Neue Wege zur kontrollierbaren Aktivierung von Arzneimitteln bionity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionity.com Daily Mail and Mail on Sunday newspapers.